5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
4.8 KiB
4.8 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Drug Control Act; adds certain chemicals to Schedules I, II, IV, and V of Act. | Drug Control Act; Schedule I; Schedule II; Schedule IV; Schedule V. Adds certain chemicals to Schedules I, II, IV, and V of the Drug Control Act. The Board of Pharmacy has added these substances in an expedited regulatory process. A substance added via this process is removed from the schedule after 18 months unless a general law is enacted adding the substance to the schedule. This bill is identical to HB 1333. | us/states/va | Virginia General Assembly | 2024 | SB 111 | Virginia SB 111 (2024) |
|
enacted |
|
3 | 27 | 5 | 2024-01-03 | 2024-03-28 | openstates | ocd-bill/d7e06f9f-50aa-4741-b6e8-f92c9fa16838 | https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB111 | 19df029b262bc2d6a25fa54ef3a40f373ca7c245239778846b4bf3a21f6740b0 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 111 (2024) — Drug Control Act; adds certain chemicals to Schedules I, II, IV, and V of Act.
Drug Control Act; Schedule I; Schedule II; Schedule IV; Schedule V. Adds certain chemicals to Schedules I, II, IV, and V of the Drug Control Act. The Board of Pharmacy has added these substances in an expedited regulatory process. A substance added via this process is removed from the schedule after 18 months unless a general law is enacted adding the substance to the schedule. This bill is identical to HB 1333.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0228 (committee substitute) — source
- Prefiled and ordered printed; offered 01/10/24 24102045D (committee substitute) — source
- SB111ER (committee substitute) — source
Votes
- Referred from Courts of Justice — 0–0 (fail) · lower
- Reported from Education and Health (15-Y 0-N) — 15–0 (pass) · upper
- Read third time and passed Senate (38-Y 0-N) — 38–0 (pass) · upper
- Reported from Health and Human Services (21-Y 0-N) — 21–0 (pass) · lower
- VOTE: Block Vote Passage (97-Y 0-N) — 96–0 (pass) · lower
Sponsors
- Mark J. Peake — primary (person)
- Christie New Craig — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-03 Prefiled and ordered printed; offered 01/10/24 24102045D
filing, introduction - 2024-01-03 Referred to Committee on Education and Health
referral-committee - 2024-01-04 Impact statement from VCSC (SB111)
- 2024-01-11 Reported from Education and Health (15-Y 0-N)
committee-passage - 2024-01-11 Impact statement from DPB (SB111)
- 2024-01-12 Read first time
reading-1 - 2024-01-15 Read second time and engrossed
reading-2 - 2024-01-16 Read third time and passed Senate (38-Y 0-N)
passage, reading-3 - 2024-02-13 Placed on Calendar
- 2024-02-13 Read first time
reading-1 - 2024-02-13 Referred to Committee for Courts of Justice
referral-committee - 2024-02-16 Referred from Courts of Justice
referral-committee - 2024-02-16 Referred to Committee on Health and Human Services
referral-committee - 2024-02-22 Reported from Health and Human Services (21-Y 0-N)
committee-passage - 2024-02-26 Read second time
reading-2 - 2024-02-27 Read third time
reading-3 - 2024-02-27 Passed House BLOCK VOTE (97-Y 0-N)
passage - 2024-02-27 VOTE: Block Vote Passage (97-Y 0-N)
passage - 2024-03-04 Enrolled
enrolled - 2024-03-04 Bill text as passed Senate and House (SB111ER)
passage - 2024-03-04 Impact statement from DPB (SB111ER)
- 2024-03-04 Signed by Speaker
passage - 2024-03-07 Signed by President
passage - 2024-03-11 Enrolled Bill Communicated to Governor on March 11, 2024
enrolled - 2024-03-11 Governor's Action Deadline 11:59 p.m., April 8, 2024
executive-receipt - 2024-03-28 Approved by Governor-Chapter 228 (effective 7/1/24)
executive-signature - 2024-03-28 Acts of Assembly Chapter text (CHAP0228)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/d7e06f9f-50aa-4741-b6e8-f92c9fa16838. Confidence: reported (aggregated from official Virginia legislature records).